Medicare drug coverage faces an ominous spending outlook

Congressional Medicare advisers reported that more than 1 in 5 enrollees hit Medicare Part D's $2,000 patient cost cap in 2025, shifting new costs to the government. Program spending is surging as drugs become more affordable due to the Inflation Reduction Act, exceeding congressional estimates.